Lambert-Eaton myasthenic syndrome

Practical Neurology

Volumn 7, Issue 4, 2007, Pages 265-267

  Petty, Richard ^a  

^a SOUTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DIAMINOPYRIDINE; AZATHIOPRINE; CREATINE KINASE; STEROID; VOLTAGE GATED CALCIUM CHANNEL;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CREATINE KINASE BLOOD LEVEL; EATON LAMBERT SYNDROME; FEMALE; HUMAN; KNEE PAIN; LIMB WEAKNESS; MUSCLE ACTION POTENTIAL; MYOPATHY; NEUROPHYSIOLOGY; PATELLA CHONDROMALACIA; PHYSICAL DISABILITY; REFLEX DISORDER; WALKING DIFFICULTY;

ADULT; CALCIUM CHANNELS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LAMBERT-EATON MYASTHENIC SYNDROME; MOTOR NEURONS; MUSCLE, SKELETAL; MYASTHENIA GRAVIS; NEUROMUSCULAR JUNCTION; POTASSIUM CHANNEL BLOCKERS; PRESYNAPTIC TERMINALS; RARE DISEASES;

EID: 34547566314     PISSN: 14747758     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.2007.120071     Document Type: Article

References (2)

1. Oh SJ, Kurokawa K, Claussen GC, et al. Electrophysiological diagnostic criteria of Lambert-Eaton myasthenic syndrome. Muscle Nerve 2005;32:515-20.
2. Maddison P, Newsom-Davis J. Treatment for Lambert-Eaton myasthenic syndrome. Cochrane Neuromuscular Disease Group, update 22. June, 2006.